Company Officially Becomes Itself LLC in Drug Probe
Published Date: 5/19/2026
Notice
Summary
The U.S. International Trade Commission has approved updating the investigation papers to reflect that Ascendis Pharma changed its name to Ascendis Pharma, LLC. This affects companies involved in a patent dispute over certain drug products with C-type natriuretic peptide variants. No delays or extra costs are expected, so the investigation keeps moving forward smoothly.
No Economic Impacts Identified for this Document
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-09984 — Certain Preserved Mushrooms from Chile, China, India, and Indonesia; Scheduling of Expedited Five-Year Reviews
The U.S. International Trade Commission is speeding up its check on whether to keep or drop special duties on preserved mushrooms from Chile, China, India, and Indonesia. This affects mushroom importers and U.S. producers, with decisions expected soon to protect American businesses from unfair pricing. The review started on May 8, 2026, and could impact prices and trade rules.
2026-10002 — Oil Country Tubular Goods From China; Determinations
The U.S. International Trade Commission decided to keep special taxes on oil country tubular goods from China because removing them could hurt American businesses soon. This means companies importing these steel pipes from China will still pay extra fees, protecting U.S. manufacturers. The decision was finalized in May 2026 and affects trade and prices going forward.
2026-09664 — Notice of Receipt of Complaint; Solicitation of Comments Relating to the Public Interest
The U.S. International Trade Commission just got a complaint about certain NAND and DRAM memory chips imported and sold in the U.S. Big tech companies like KIOXIA and SK hynix are involved, and the Commission wants your thoughts on how this might affect the public. This could lead to import bans or sales stops, so keep an eye out for changes that might shake up the tech market soon!
2026-09537 — Notice of Receipt of Complaint; Solicitation of Comments Relating to the Public Interest
The U.S. International Trade Commission got a complaint from Xockets, Inc. saying some big tech companies like NVIDIA, Microsoft, and Amazon might be selling certain GPU and data processing tech illegally in the U.S. The Commission wants your thoughts on how this could affect the public before deciding on possible bans or restrictions. This could lead to changes in what products are allowed and might impact sales during a 60-day review period.
2026-09531 — Crystalline Silicon Photovoltaic Cells, Whether or Not Assembled Into Modules, From India, Indonesia, and Laos; Scheduling of the Final Phase of Antidumping and Countervailing Duty Investigations
The U.S. is investigating whether solar panels and cells from India, Indonesia, and Laos are being unfairly priced or subsidized, which might hurt American solar businesses. This final review will decide if extra taxes should be added to these imports to protect U.S. companies. The investigation started on April 28, 2026, and could impact prices and trade soon.
2026-09445 — Non-Oriented Electrical Steel From China, Germany, Japan, South Korea, Sweden, and Taiwan; Determinations
The U.S. International Trade Commission decided to keep special taxes (called duties) on certain steel from China, Germany, Japan, South Korea, Sweden, and Taiwan. These taxes help protect American steel makers from unfair competition. If the taxes were removed, U.S. steel companies could get hurt again, so the duties will stay in place starting now.
Previous / Next Documents
Previous: 2026-10009 — Sunshine Act Meetings
The Unified Carrier Registration (UCR) Task Force is holding a public meeting on May 27, 2026, to discuss updates to the UCR Plan and Agreement that affect carriers who register for interstate transportation. They’ll review past meeting notes, consider changes, and set the stage for smoother registration processes. No new fees or costs are mentioned, but staying tuned is key for carriers and stakeholders.
Next: 2026-10012 — Advisory Committee on Immunization Practices (ACIP); Notice of Charter Re-Establishment
The CDC is officially bringing back the Advisory Committee on Immunization Practices (ACIP) for another two years after a paperwork mix-up caused a brief pause. This committee helps guide vaccine decisions that affect everyone’s health, so its return keeps important vaccine advice on track without extra costs or delays. The re-establishment shows the CDC’s commitment to keeping us safe and informed about immunizations.